Twist Bioscience Corp

0ME

Company Profile

  • Business description

    Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company’s proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

  • Contact

    681 Gateway Boulevard
    South San FranciscoCA94080
    USA

    T: +1 800 719-0671

    https://www.twistbioscience.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    30 September 2026

    Employees

    979

Stocks News & Analysis

stocks

Ask the Analyst: Why are ASX gold miners overvalued despite a near record gold price?

All that glitters is not gold.
stocks

Chart of the Week: Looking past the oil shock to find consumer opportunities

Shoppers are being hit by double whammy of oil and rising rates.
stocks

ASX data center player sells US assets to bolster balance sheet

Asset sale in response to growing investor concerns.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,092.9022.800.25%
CAC 408,299.42237.112.94%
DAX 4024,918.69516.992.12%
Dow JONES (US)49,910.59612.341.24%
FTSE 10010,438.66219.552.15%
HKSE26,558.58344.801.32%
NASDAQ25,838.94512.822.02%
Nikkei 22562,915.873,402.755.72%
NZX 50 Index13,244.8999.700.76%
S&P 5007,365.12105.901.46%
S&P/ASX 2008,866.5021.100.24%
SSE Composite Index4,167.397.220.17%

Market Movers